Siemens Healthineers has launched its Clinitest Rapid COVID-19 Antigen Test in Europe, which can identify persons infected with SARS-CoV-2 in 15 minutes.
https://european-biotechnology.com/wp-content/uploads/2024/04/AML.jpg512739Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2020-10-13 08:14:322020-10-13 08:14:32Priothera closes €30m Series A financing
/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png00h.genrich/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngh.genrich2020-10-07 10:37:002020-10-07 10:37:00MiNA Therapeutics with new CBO
https://european-biotechnology.com/wp-content/uploads/2024/04/Bildschirmfoto_2020-10-06_um_08.14.58.png351520Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2020-10-06 07:54:022020-10-06 07:54:02Santhera ends development of idebenone
A $77 Series B financing allows Dewpoint Therapeutics Inc to select a lead programme from its new drug class of molecular condensates and push proof-of-concept studies.
https://european-biotechnology.com/wp-content/uploads/2024/04/Bildschirmfoto_2020-09-30_um_14.33.20.png481481Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2020-09-30 14:01:522020-09-30 14:01:52Dewpoint Therapeutics raise $77m in Series B financing
https://european-biotechnology.com/wp-content/uploads/2024/04/Liquid_Biopsy_Main_1.jpg3381000Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2020-09-29 08:26:002020-09-29 08:26:00Kurma Partners close diagnostics fund at €50m
Siemens launches COVID-19 antigen lateral flow test
Latest NewsSiemens Healthineers has launched its Clinitest Rapid COVID-19 Antigen Test in Europe, which can identify persons infected with SARS-CoV-2 in 15 minutes.
Priothera closes €30m Series A financing
Latest NewsPriothera Ltd. wants to use €30m from a Series A financing to develop a licenced therapy for acute myeloid leukemia (AML).
COVID-19 jab: EU signs contract with JNJ
Latest NewsJohnson & Johnson (JNJ) has inked a contract with the European Commission to supply 200 million doses of its COVID-19 vaccine to the European Union.
MiNA Therapeutics with new CBO
AppointmentsPeter Bains started at MiNA Therapeutics as new Chief Business Officer at the end of September.
Santhera ends development of idebenone
Latest NewsSwiss Santhera Pharmaceuticals has discontinued Phase III development of its DMD drug and will restructure its pipeline.
Nobel Prize in Physiology for HCV pioneers
Latest NewsThe Nobel Prize in Physiology or Medicine goes to Harvey J. Alter, Michael Houghton and Charles M. Ric
Swiss Sophia Genetics to expand globally
Latest NewsSwiss Sophia Genetics has raised $110m, to expand marketing of its AI-driven cancer and genetic disease decision support platform globally.
EIB and EC launch circular bioeconomy fund
Latest NewsThe European Commission (EC) and the European Investment Bank (EIB) have launched a circular bioeconomy fund with a target size of €250m.
·
Dewpoint Therapeutics raise $77m in Series B financing
Latest NewsA $77 Series B financing allows Dewpoint Therapeutics Inc to select a lead programme from its new drug class of molecular condensates and push proof-of-concept studies.
Kurma Partners close diagnostics fund at €50m
Latest NewsThe only investment fund dedicated to breakthrough diagnostics, Kurma Diagnostics 2, had its first closing at €50m.